Search Contract Opportunities

Tamiflu 75mg & 30mg - Award Notice   3

ID: 75A50324F80002 • Type: Award Notice

Description

Tamiflu 75mg capsules (NDC 0004-0800-85) and Tamiflu 30mg capsules (NDC 0004-0802-85).

Overview

Awardee
Genentech USA
Award ID
36F79723D0219
Reported Award
$396,999,520
Award Date
Nov. 17, 2023
Posted
Nov. 27, 2023, 1:54 p.m. EST
Set Aside
None
Place of Performance
Not Provided
Source
SAM

Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Tamiflu 75mg & 30mg - Award Notice (75A50324F80002) was awarded to Genentech USA on 11/27/23 by HHS Office of the Assistant Secretary for Preparedness and Response.
Primary Contact
Name
Kimberly Golden   Profile
Email
Phone
None

Documents

Posted documents for Award Notice 75A50324F80002

Question & Answer

Opportunity Lifecycle

Procurement notices related to Award Notice 75A50324F80002

Award Notifications

Agency published notification of awards for Award Notice 75A50324F80002

Similar Active Opportunities

Open contract opportunities similar to Award Notice 75A50324F80002

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > ASPR/ORM-SNS
FPDS Organization Code
7505-75A503
Source Organization Code
500175942
Last Updated
Dec. 2, 2023
Last Updated By
sherica.teshome@hhs.gov
Archive Date
Dec. 2, 2023